The female pill was launched in the UK more than 50 years ago. After years of development, a revolutionary male oral contraceptive pill - known as 11-beta-MNTDC - has passed initial stages of testing in humans.
None of the men involved in test suffered any serious issues, with only some minor symptoms reported including low-level erectile dysfunction, fatigue, acne, headaches, and reduced libido. Throughout the trial, no participant stopped taking the drug because of the side effects. The pill for men works in a similar way to the female contraceptive pill, containing a mix of hormones. In this case is about testosterone and progestin (a synthetic version of the female hormone progesterone). The research from the Los Angeles Biomedical Research Institute (LA BioMed) and the University of Washington show promising results.
This drug managed to safely reduce hormones required for sperm reduction without drastically affecting men's sex drives or sexual performance. "11-beta-MNTDC mimics testosterone through the rest of the body but is not concentrated enough in the testes to support sperm production," professor of medicine at the University of Washington School of Medicine, Stephanie Page said. More tests will be, the drug has not yet been submitted for approval by the Food and Drug Administration. On the other side, A UK survey by Anglia Ruskin University, in 2011, found 70 out of 134 women would worry that their male partner would forget to take a pill.